Model Number VITD TOTAL |
Device Problem
Low Test Results (2458)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 03/27/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
This event occurred in (b)(6).
|
|
Event Description
|
The initial reporter complained of discrepant results for 1 patient tested for vitamin d total (vitamin d) and elecsys vitamin d total ii (vitamin d ii) on a cobas 8000 e 602 module and a cobas e801 module.This medwatch will cover vitamin d.Refer to medwatch with patient identifier (b)(6) for information on the vitamin d ii results.The initial vitamin d ii result from the e801 module was 35.9 ng/ml.The sample was repeated using vitamin d on the e602 module and the result was 3.00 ng/ml.The customer re-centrifuged the sample and repeated it on the e602 module with a result of 6.52 ng/ml.The customer performed a 1:2 dilution and repeated the sample on the e602 module with a result of 26.7 ng/ml.The customer reported the vitamin d ii result of 35.9 ng/ml outside of the laboratory.It is not clear which results the customer believes to be correct.A new sample was obtained from the patient on (b)(6) 2019 and the vitamin d ii result from the e801 module was 66.5 ng/ml.The customer attempted to run this sample on the e602 module, however, an alarm message was received with no result.The customer observed a clot at the sipper probe.There was no allegation that an adverse event occurred.The e602 module serial number was (b)(4).The e801 module serial number was not provided.
|
|
Manufacturer Narrative
|
The customer testing a sample from the patient by liquid chromatography-tandem mass spectrometry (lcms/ms) and the vitamin d ii result was 21.67 ng/ml.The investigation tested a sample from the patient on an e801 module.The investigation was able to reproduce the customer's vitamin d and vitamin d ii results.The investigation tested this patient sample by the lcms/ms method and received a vitamin d ii result (18.9 ng/ml) that was comparable to the customer's lcms/ms result of 21.67 ng/ml.Investigations are ongoing.
|
|
Manufacturer Narrative
|
The investigation determined that the difference in results between vitamin d and vitamin d ii assays are related to an unknown issue with the patient sample; the patient is a cancer patient with an unknown blood composition.The investigation did not identify a product problem.The cause of the event could not be determined.
|
|
Search Alerts/Recalls
|